Hexaware Named a Leader and Rising Star in the ISG Provider Lens® Life Sciences Digital Services 2026 Global Quadrant Report
May 5, 2026
Information Services Group (ISG), a leading global technology research and advisory firm, has named Hexaware a Leader in Clinical Development (Service Providers) and Patient Engagement (Service Providers), and a Rising Star in Commercial Operations – Digital Evolution (Service Providers) in the ISG Provider Lens® Life Sciences Digital Services 2026 Global Quadrant Report. Some of the top service providers recognized across these quadrants include Hexaware, Accenture, Capgemini, Cognizant, Deloitte, HCLTech, Indegene, Infosys, NTT DATA, TCS, Tech Mahindra, and Wipro, among others.
As life sciences enterprises shift from isolated digital interventions to connected, AI-enabled operating models, the demand for partners that combine domain depth, regulatory rigor, and digital acceleration is intensifying. Hexaware’s recognition across three quadrants reflects its ability to meet this demand through an AI-first, platform-driven approach built on proprietary IP, production-grade agentic AI, and domain-led execution across the Molecule-to-Market value chain.
Analyst Perspective
“Hexaware is emerging as a focused and execution-driven player in life sciences, with a clear emphasis on embedding AI across the molecule-to-market value chain. Its clinical development capabilities, anchored in platforms like CDAaaS and Agentverse™, highlight a pragmatic approach to reducing cycle times and improving data quality through production-grade agentic AI. In parallel, its AI-first Patient 360 framework and GenAI-powered engagement models enable highly personalized, compliant patient journeys. Coupled with a launch-centric commercial ecosystem and strong platform partnerships, Hexaware demonstrates a well-integrated approach to driving measurable outcomes across clinical, patient and commercial operations.”
— Rohan Sinha, Lead Author, Senior Manager and Principal Analyst, ISG
Clinical Development: Leader
In Clinical Development, ISG recognized Hexaware for embedding AI and agentic orchestration as foundational elements of its strategy, with a clear focus on cycle time reduction, faster submissions, and improved data quality. Central to this recognition is Hexaware’s Clinical Data Automation as a Service (CDAaaS) platform — an Electronic Data Capture (EDC)-agnostic solution delivering end-to-end capabilities across ingestion, harmonization, validation, analytics, and submission readiness — and Agentverse™, which unifies feasibility, data management, and medical writing workflows through agent-based automation. ISG noted measurable gains, such as faster study builds and feasibility cycles, as evidence of operational maturity.
Patient Engagement: Leader
In Patient Engagement, ISG recognized Hexaware for enabling AI-first patient engagement solutions through a unified Patient 360 platform integrating Real-World Evidence (RWE), Electronic Health Records (EHR), Customer Relationship Management (CRM), wearable, and support program data, with AI-driven segmentation and next-best-action engines orchestrating hyperpersonalized journeys across omnichannel touchpoints — email, SMS, apps, portals, and contact centers. ISG specifically called out Hexaware’s GenAI and agentic conversational ecosystem spanning virtual companions, dynamic content generation, and therapy support programs. The report also highlighted Hexaware’s compliance-centric care model, noting built-in governance, Protected Health Information (PHI)/Personally Identifiable Information (PII) safeguards, auditability, and human-in-the-loop review ensuring responsible AI deployment across patient- and HCP-facing workflows.
Commercial Operations – Digital Evolution: Rising Star
In Commercial Operations, ISG recognized Hexaware as a Rising Star, citing its strong Salesforce, Veeva, and IQVIA partnerships, a validated Salesforce-based Cell and Gene Therapy platform, and an AI-enhanced Digital Content Factory. ISG highlighted Hexaware’s launch-centric commercial ecosystem, noting support for over 60 brand launches with accelerators spanning sales, marketing, market access, and patient engagement. Hexaware’s proprietary platforms enable targeted, compliant engagement across healthcare provider (HCPs), patient, and payer stakeholders, strengthened by predictive forecasting and AI-driven campaign optimization. The report also called out advanced commercial analytics capabilities — including KOL 360 insights, managed markets MDM, and next-best-action intelligence — providing predictive decision support with high first-resolution rates globally.
Hexaware Named a Leader in Clinical Development (Service Providers) in the ISG Provider Lens® Life Sciences Digital Services 2026 Global Quadrant Report
Hexaware Named a Leader in Patient Engagement (Service Providers) in the ISG Provider Lens® Life Sciences Digital Services 2026 Global Quadrant Report
Hexaware Named a Rising Star in Commercial Operations – Digital Evolution (Service Providers) in the ISG Provider Lens® Life Sciences Digital Services 2026 Global Quadrant Report
“Hexaware delivers AI-powered, launch-focused commercial transformation for life sciences, combining deep platform partnerships, GenAI accelerators and purpose-built pharma ecosystems to drive measurable brand and field performance.” — Sneha Jayanth, Report Author, Lead Analyst, ISG.
To learn more about our life sciences practice click here.